Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: Soo Labs II, Inc., 3764 [2023-01030]

Download as PDF 3764 Federal Register / Vol. 88, No. 13 / Friday, January 20, 2023 / Notices DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–1106] Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: Soo Labs II, Inc. Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to its regulations governing the program of growing marihuana for scientific and medical research under DEA registration. SUMMARY: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before March 21, 2023. ADDRESSES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. SUPPLEMENTARY INFORMATION: The Controlled Substances Act (CSA) prohibits the cultivation and distribution of marihuana except by persons who are registered under the CSA to do so for lawful purposes. In accordance with the purposes specified in 21 CFR 1301.33(a), DEA is providing notice that the entity identified below has applied for registration as a bulk manufacturer of schedule I controlled substances. In response, registered bulk manufacturers of the affected basic class(es), and applicants therefor, may submit electronic comments on or objections of the requested registration, lotter on DSK11XQN23PROD with NOTICES1 DATES: VerDate Sep<11>2014 17:29 Jan 19, 2023 Jkt 259001 as provided in this notice. This notice does not constitute any evaluation or determination of the merits of the application submitted. The applicant plans to manufacture bulk active pharmaceutical ingredients (APIs) for product development and distribution to DEA registered researchers. If the application for registration is granted, the registrant would not be authorized to conduct other activity under this registration aside from those coincident activities specifically authorized by DEA regulations. DEA will evaluate the application for registration as a bulk manufacturer for compliance with all applicable laws, treaties, and regulations and to ensure adequate safeguards against diversion are in place. As this applicant has applied to become registered as a bulk manufacturer of marihuana, the application will be evaluated under the criteria of 21 U.S.C. 823(a). DEA will conduct this evaluation in the manner described in the rule published at 85 FR 82333 on December 18, 2020, and reflected in DEA regulations at 21 CFR part 1318. In accordance with 21 CFR 1301.33(a), DEA is providing notice that on May 11, 2022, Soo Labs II, Inc., 1415 Industrial Park Drive, Sault Sainte Marie, Michigan 49783–1455, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substances: Drug code Controlled substance Marihuana ..................... Tetrahydrocannabinols I 7360 7370 Schedule I I I Matthew Strait, Deputy Assistant Administrator. [FR Doc. 2023–01030 Filed 1–19–23; 8:45 am] BILLING CODE P LEGAL SERVICES CORPORATION Sunshine Act Meetings The Legal Services Corporation (LSC) Board of Directors and its committees will meet January 22–24, 2023. On Sunday, January 22, the first meeting will begin at 1:30 p.m. MST, with the next meeting commencing promptly upon adjournment of the immediately preceding meeting. On Monday, January 23, the first meeting will again begin at 8:30 a.m. MST, with the next meeting commencing promptly upon adjournment of the immediately TIME AND DATE: PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 preceding meeting. On Tuesday, January 24, the first meeting will begin at 8:00 a.m. MST, with the next meeting commencing promptly upon adjournment of the immediately preceding meeting. PLACE: Public Notice of Hybrid Meeting. LSC will conduct its January 22–24, 2023 meetings at the Sheraton Phoenix Downtown Hotel, 340 North 3rd Street, Phoenix, AZ 85004, and virtually via Zoom. Public Observation: Unless otherwise noted herein, the Board and all committee meetings will be open to public observation. Members of the public who wish to participate virtually in the public proceedings may do so by following the directions provided below. Directions for Open Sessions Sunday, January 22, 2023 • To join the Zoom meeting by computer, please use this link. Æ https://lsc-gov.zoom.us/j/ 88994750560?pwd=aGhaK3hLN2R4 TFRSZExJNTlUZHN2UT09. Æ Meeting ID: 889 9475 0560. Æ Passcode: 012223. Monday, January 23, 2023 • To join the Zoom meeting by computer, please use this link. Æ https://lsc-gov.zoom.us/j/ 88651677172?pwd=am92YVZINUl USlVaUnBkcjFSbWltUT09. Æ Meeting ID: 886 5167 7172. Æ Passcode: 012323. Tuesday, January 24, 2023 • To join the Zoom meeting by computer, please use this link. Æ https://lsc-gov.zoom.us/j/ 82342982872?pwd=eGxicWR2bDVUR HhNZmdqMTl0blV5dz09. Æ Meeting ID: 823 4298 2872. Æ Passcode: 012423. Æ If calling from outside the U.S., find your local number here: https://lscgov.zoom.us/u/acCVpRj1FD. Once connected to Zoom, please immediately mute your computer or telephone. Members of the public are asked to keep their computers or telephones muted to eliminate background noise. To avoid disrupting the meetings, please refrain from placing the call on hold if doing so will trigger recorded music or other sound. From time to time, the Board or Committee Chair may solicit comments from the public. To participate in the meeting during public comment, use the ‘raise your hand’ or ‘chat’ functions in Zoom and wait to be recognized by the Chair before stating your questions and/ or comments. E:\FR\FM\20JAN1.SGM 20JAN1

Agencies

[Federal Register Volume 88, Number 13 (Friday, January 20, 2023)]
[Notices]
[Page 3764]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-01030]



[[Page 3764]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1106]


Bulk Manufacturer of Controlled Substances Application: Bulk 
Manufacturer of Marihuana: Soo Labs II, Inc.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: The Drug Enforcement Administration (DEA) is providing notice 
of an application it has received from an entity applying to be 
registered to manufacture in bulk basic class(es) of controlled 
substances listed in schedule I. DEA intends to evaluate this and other 
pending applications according to its regulations governing the program 
of growing marihuana for scientific and medical research under DEA 
registration.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
March 21, 2023.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to https://www.regulations.gov and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be aware that submitted comments are not instantaneously 
available for public view on https://www.regulations.gov. If you have 
received a Comment Tracking Number, your comment has been successfully 
submitted and there is no need to resubmit the same comment.

SUPPLEMENTARY INFORMATION: The Controlled Substances Act (CSA) 
prohibits the cultivation and distribution of marihuana except by 
persons who are registered under the CSA to do so for lawful purposes. 
In accordance with the purposes specified in 21 CFR 1301.33(a), DEA is 
providing notice that the entity identified below has applied for 
registration as a bulk manufacturer of schedule I controlled 
substances. In response, registered bulk manufacturers of the affected 
basic class(es), and applicants therefor, may submit electronic 
comments on or objections of the requested registration, as provided in 
this notice. This notice does not constitute any evaluation or 
determination of the merits of the application submitted.
    The applicant plans to manufacture bulk active pharmaceutical 
ingredients (APIs) for product development and distribution to DEA 
registered researchers. If the application for registration is granted, 
the registrant would not be authorized to conduct other activity under 
this registration aside from those coincident activities specifically 
authorized by DEA regulations. DEA will evaluate the application for 
registration as a bulk manufacturer for compliance with all applicable 
laws, treaties, and regulations and to ensure adequate safeguards 
against diversion are in place.
    As this applicant has applied to become registered as a bulk 
manufacturer of marihuana, the application will be evaluated under the 
criteria of 21 U.S.C. 823(a). DEA will conduct this evaluation in the 
manner described in the rule published at 85 FR 82333 on December 18, 
2020, and reflected in DEA regulations at 21 CFR part 1318.
    In accordance with 21 CFR 1301.33(a), DEA is providing notice that 
on May 11, 2022, Soo Labs II, Inc., 1415 Industrial Park Drive, Sault 
Sainte Marie, Michigan 49783-1455, applied to be registered as a bulk 
manufacturer of the following basic class(es) of controlled substances:

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Marihuana..............................     7360  I
Tetrahydrocannabinols..................     7370  I
------------------------------------------------------------------------


Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023-01030 Filed 1-19-23; 8:45 am]
BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.